GM3 ganglioside inhibits endothelin-1-mediated signal transduction in C6 glioma cells

Rosaria Bassi, Paola Viani, Paola Giussani, Laura Riboni, Guido Tettamanti

Research output: Contribution to journalArticlepeer-review


We found that sparse and confluent C6 glioma cells differ both in GM3 content, which increases with cell density, and in endothelin-1 (ET-1)-induced phosphoinositide hydrolysis, which was markedly higher in the sparse cells than in the confluent. Also after manipulation of the cellular GM3 content through treatment with exogenous GM3 or with drugs known to affect GM3 metabolism, the ET-1 effect was inversely related to GM3 cellular levels. Cell treatment with an anti-GM3 mAb resulted in the enhancement of ET-1-induced phospholipase C activation and restored the capacity of GM3-treated cells to respond to ET-1. These findings suggest that the GM3 ganglioside represents a physiological modulator of ET-1 signaling in glial cells.

Original languageEnglish
Pages (from-to)101-104
Number of pages4
JournalFEBS Letters
Issue number1
Publication statusPublished - Oct 19 2001


  • C6 glioma cells
  • Endothelin
  • Glial cell
  • GM3 ganglioside
  • Inositol phosphate

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology


Dive into the research topics of 'GM3 ganglioside inhibits endothelin-1-mediated signal transduction in C6 glioma cells'. Together they form a unique fingerprint.

Cite this